These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence. Wong KS; Li YJ; Howard J; Ben-David Y Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829 [TBL] [Abstract][Full Text] [Related]
4. Identification of the erythropoietin receptors of erythroleukemic cells. Wang FF; Wang YJ; Lee HJ; Fong JC Biochem Int; 1989 Jan; 18(1):163-71. PubMed ID: 2541719 [TBL] [Abstract][Full Text] [Related]
5. Studies of erythropoietin gene expression in the mouse erythroleukemic cell lines IW32 and NN10. Beru N; Goldwasser E Prog Clin Biol Res; 1989; 319():459-63; discussion 464-6. PubMed ID: 2622925 [No Abstract] [Full Text] [Related]
6. Biochemical analyses of murine erythropoietin from plasma and from cloned erythroleukemia cells. Choppin J; Egrié J; Casadevall N; Lacombe C; Muller O; Varet B Exp Hematol; 1987 Feb; 15(2):171-6. PubMed ID: 3469104 [TBL] [Abstract][Full Text] [Related]
7. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856 [TBL] [Abstract][Full Text] [Related]
8. Increased erythropoietin sensitivity after in vitro transformation of hematopoietic precursors by RNA tumor viruses. Hankins WD J Natl Cancer Inst; 1983 Apr; 70(4):725-34. PubMed ID: 6572760 [TBL] [Abstract][Full Text] [Related]
9. [Production of an erythropoietic factor by mouse leukemia]. Tambourin P; Wendling F; Bucau-Varlet P; Charon M; Muller O; Casadevall N; Lacombe C; Choppin J; Varet B C R Seances Acad Sci III; 1983; 297(1):29-31. PubMed ID: 6416628 [TBL] [Abstract][Full Text] [Related]
10. Characterization of erythropoietin produced by IW32 murine erythroleukemia cells. Choppin J; Lacombe C; Casadevall N; Muller O; Tambourin P; Varet B Blood; 1984 Aug; 64(2):341-7. PubMed ID: 6589018 [TBL] [Abstract][Full Text] [Related]
11. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658 [TBL] [Abstract][Full Text] [Related]
12. A sensitive new bioassay for erythroid colony-stimulating factor. Feldman L; Davis KL; Feeley DM; Sytkowski AJ Exp Hematol; 1993 Dec; 21(13):1657-62. PubMed ID: 8243567 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin, an autocrine regulator? Serum-free production of erythropoietin by cloned erythroid cell lines. Hankins WD; Schooley J; Eastment C Blood; 1986 Jul; 68(1):263-8. PubMed ID: 3459557 [TBL] [Abstract][Full Text] [Related]
14. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment. Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053 [TBL] [Abstract][Full Text] [Related]
15. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861 [TBL] [Abstract][Full Text] [Related]
16. Abnormal erythropoietin (Epo) gene expression in the murine erythroleukemia IW32 cells results from a rearrangement between the G-protein beta2 subunit gene and the Epo gene. Chrétien S; Duprez V; Maouche L; Gisselbrecht S; Mayeux P; Lacombe C Oncogene; 1997 Oct; 15(16):1995-9. PubMed ID: 9365246 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the early and late stages of myelomonocytic leukemia induced by Friend helper-independent virus F-MuLV: isolation and induction of Friend myelomonocytic leukemic cell lines. Shibuya T; Mak TW J Cell Physiol; 1983 Dec; 117(3):283-9. PubMed ID: 6581171 [TBL] [Abstract][Full Text] [Related]
18. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
19. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice. Fagg B; Ostertag W J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173 [TBL] [Abstract][Full Text] [Related]
20. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis. Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]